Ticker ALPN – Alpine Immune Sciences – sales, description, marketcap – Tickerday.com

ALPN

Alpine Immune Sciences

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 200.98M; Volume: 7.40K; AvgVol 3m: 81.63K; Beta: 1.16;

Cost estimate:

P/E: ; EPS: -1.78; EPS growth quarter/prev quarter: 16.30%;

EPS growth this year: 13.50%; EPS growth past 5 years: 12.20%;

EPS ttm: -1.78;

P/S: 73.02; P/B: 10.45; P/Cashflow: 2.43; P/FCF: 7.91;

Sales: 2.95M; Sales growth quarter/prev quarter: 16.70%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -48.80%; ROE – return on equity: -125.50%; LT Debt/Equity: 0.61; Total Debt/Equity: 0.62;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 0.50%; Insider Transactions:0.00%;

Institutional Ownership: 29.80%; Institutional Transactions: -11.26%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *